Non-Competitive Inhibition of Xanthine Oxidase by N-Nitrosomorpholine: An In Vitro Study
Abstract
Nitrosamines can be formed from nitrate. Nitrate is not actually toxic to mammals but can be reduced to nitrite. Nitrite, on the other hand, reacts with amino groups to form the carcinogenic N-nitroso compound. N-nitrosomorpholine (NMOR) is a carcinogenic compound that is included in the nitrosamine class and is the most common type of nitrosamines. Xanthine oxidase (XO) is an enzyme that catalyzes the hydroxylation of hypoxanthine to xanthine and xanthine to uric acid in purine metabolism. Excessive production and/or inadequate excretion of uric acid causes hyperuricemia. This condition is associated with kidney and cardiovascular diseases, especially gout. In order to prevent hyperuricemia and therefore gout, suppressing the activity of the XO enzyme is one of the main targets. In our study, the possible inhibitory effects of NMOR on the activity of the XO enzyme were investigated by spectrophotometric method. XO activity was evaluated in the presence of different concentrations of NMOR and analyzed using Lineweaver-Burk plot. The Km value was determined as 0.55 mM and the Vmax value was determined as 2.45 U/ml. Finally, it was determined that the XO enzyme was inhibited non-competitively by NMOR. Inhibition of XO enzyme with the help of NMOR may lead to functional deficiencies by disrupting the pathway in which purines are metabolized, as well as mediating the control of the production of uric acid formed in purine metabolism. More advanced methods and in vivo studies are needed to better understand the effects of NMOR on the organism and XO enzyme
Keywords
Xanthine Oxidase, Nitrosamine, Nitrosomorpholine, Non-competitive inhibition, Purine metabolism
Supporting Institution
Yok
Project Number
Yok
Ethical Statement
Yazarlar arasında herhangi bir çıkar çatışması bulunmamaktadır.
Thanks
Yok
References
- [1] Swann P.F., The toxicology of nitrate, nitrite and n‐nitroso compounds, Journal of the Science of Food and Agriculture, 26 (11) (1975) 1761-1770.
- [2] Ozbay S., Sireli U.T., Filazi A., Nitrosamines, their chemistries and effects on health, Int. J. Sci. Technol. Res., 5 (4) (2019) 124-133.
- [3] Deveci G., Tek N.A., N‐Nitrosamines: a potential hazard in processed meat products. Journal of the Science of Food and Agriculture, 104 (5) (2024) 2551-2560.
- [4] Xie Y., Geng Y., Yao J., Ji J., Chen F., Xiao J., ... & Ma L., N-nitrosamines in processed meats: Exposure, formation and mitigation strategies. Journal of Agriculture and Food Research, 13 (2023) 100645.
- [5] Li Y., Hecht S.S., Metabolic activation and DNA interactions of carcinogenic N-nitrosamines to which humans are commonly exposed, International journal of molecular sciences, 23 (9) (2022) 4559.
- [6] Zhao B., Zhou J., Nakada N., Ihara M., Liu Y., Wong Y.J., ... & Tanaka H., COVID-19 impacts on characterization of N-nitrosamines and their precursors during transport in sewer systems, Water Research, 279 (2025) 123439.
- [7] Meng X.J., Liu X.D., Zhang X.M., Hu Y., Guo Q.F.,. Determination of 8 N-nitrosamines in the workplace air by GC-MS/MS method, Chinese journal of industrial hygiene and occupational diseases, 42 (8) (2024) 616-620.
- [8] Brunnemann K.D., Hoffmann D., Decreased concentrations of N-nitrosodiethanolamine and N-nitrosomorpholine in commercial tobacco products, Journal of agricultural and food chemistry, 39 (1) (1991) 207-208.
- [9] Schmidtsdorff S., Neumann J., Schmidt A.H., Parr M.K., Prevalence of nitrosamine contaminants in drug samples: Has the crisis been overcome?, Archiv der Pharmazie, 356 (2) (2023) 2200484.
- [10] Steinberg P., Klingelhöffer A., Schäfer A., Wüst G., Weisse G., Oesch F., Eigenbrodt E., Expression of pyruvate kinase M 2 in preneoplastic hepatic foci of N-nitrosomorpholine-treated rats, Virchows Archiv, 434 (1999) 213-220.